Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase NA 2Phase 1/2 1

Status

Completed 4

Sponsor Class

NIH 2OTHER 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Other solid neoplasm 1

Conditions

Colonic Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Rectal Neoplasms 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Resveratrol × Clear all
NCT00920803 2017-06-14

A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases

GlaxoSmithKline

Phase 1 Completed
9 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00433576 2014-09-15

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00256334 2014-06-20

Resveratrol for Patients With Colon Cancer

University of California, Irvine

Phase 1 Completed
11 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT00098969 2012-12-17

IRB 2004-535

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡